Ventricular assist device market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 11.40% in the above-mentioned forecast period. Rise in the awareness about the heart failure treatment among population drives the ventricular assist device market.
Ventricular Assist Device Market
Market Analysis and Insights: Ventricular Assist Device Market
This Ventricular Assist Device Market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on the Ventricular Assist Device Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
On the Basis of Product, the Ventricular Assist Device Market Is Primarily Split Into
- Small Size
- Medium Size
- Large Size
Get the sample copy of Report here:
Ventricular Assist Device Market Country Level Analysis
The countries covered in the Ventricular Assist Device Market report are
- U.S.,
- Canada and Mexico in North America,
- Germany,
- France,
- U.K.,
- Italy,
- Spain,
- Turkey,
- Rest of Europe in Europe,
Market Segment Analysis:
The Semi-Extensible Ventricular Assist Device Market Report provides a primary review of the industry along with definitions, classifications, and enterprise chain shape. Market analysis is furnished for the worldwide markets which include improvement tendencies, hostile view evaluation, and key regions development.
Full Access to Report:
https://www.databridgemarketresearch.com/reports/global-ventricular-assist-device-market
Key questions answered in the report:
- What is the Ventricular Assist Device Market’s growth potential?
- Which product category will be the most profitable?
- What are the top companies in the global Ventricular Assist Device Market?
- What are the main trends that are positively impacting the Market’s growth?
Table of Contents
- Executive Summary
- Market Landscape
- Vendor Landscape
- Vendor Analysis
Get TOC Details:
https://www.databridgemarketresearch.com/toc/?dbmr=global-ventricular-assist-device-market
Key Players Ventricular Assist Device Market
The major players covered in the ventricular assist device market report are
· Abbott,
· ABIOMED.,
· Berlin Heart,
· BiVACOR Inc.,
· ReliantHeart Inc.,
· Calon Cardio-Technology Ltd,
Browse Related Reports@
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
The global ventricular assist device market size is expected to reach USD 4.1 billion by 2027, according to a new report by Radiant Insights, Inc., registering a CAGR of 11.7% over the forecast period.
Increase in prevalence of cardiovascular diseases such as congenital heart diseases, heart failure, hypertension, ventricular septal defect, and stroke due to rise in adoption of unhealthy lifestyle habits such as physical inactivity, smoking, and alcohol consumption drives the demand for ventricular assist devices (VADs).
According to estimates published by the United Nations in 2012, the global geriatric population was nearly 809.4 million and is expected to witness a twofold increase by 2050 with an estimated population of over 2,000 million.
Geriatric population has a high risk of various cardiovascular diseases and a majority of them are expected to suffer from heart failure or stroke.
For instance, the United Kingdom National Health Service (UK NHS) financed a bridge-to-transplant (BTT) program in which left ventricular assist devices (LVADs) such as HeartMate II and HeartWare are used for treating patients.
The increasing patient pool for cardiovascular disorders, coupled with growing demand for mechanical assist devices, is expected to drive the demand for VADs over the forecast period.
